Hormonal changes during menopause can lead to skin changes, increasing the likelihood of rosacea developing or worsening. The decline in estrogen levels during menopause can affect blood vessels ...
ACUD-1 is under clinical development by Accuitis and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success rate (PTSR) indication ...
Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...
Rosacea is a common skin malady characterized ... in kids with Crohn's Disease A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease ...
It's called jock itch when ringworm affects the groin. Rosacea is a skin condition that causes facial redness and sometimes burning or stinging. Other symptoms may include acne-like skin sores ...